Evidence map›Paper›PMID 41815362›Full record

ArticleAsian journal of urology2026

Trends and projections in prostate cancer epidemiology in Thailand: A population-based cancer registry analysis.

Danai Manorom

Abstract read
In one paragraph

Article in Asian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Danai ManoromNational Cancer Institute of Thailand, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate trends in the incidence and mortality of prostate cancer (PCa) in Thailand from 1990 to 2017 and project future rates up to 2040. It also aimed to examine incidence and mortality trends across 12 health districts and Bangkok from 2012 to 2020. Methods: Data on PCa cases diagnosed between 1990 and 2017 were obtained from Thailand's Population-based Cancer Registry. Age-specific incidence rates were adjusted to the Segi World Standard Population as recommended by the WHO. The joinpoint regression analysis identified significant changes in trends and estimated the annual percent change. Projections were made using the joinpoint regression model. District-specific incidence rates and mortality rates from 2012 to 2020 were calculated for 12 health districts and Bangkok. Results: From 1990 to 2017, 18 192 new PCa cases were diagnosed in Thailand, with 95% in men aged 50 years and older. The age-standardised incidence rate more than doubled from 3.84 to 7.72 cases per 100 000 person-years, with a significant estimated annual percent change of 2.7% (95% CI 1.7%-4.1%; Conclusion: PCa incidence rates and mortality rates in Thailand have significantly increased over the past decades. With an aging population, these trends are expected to continue, posing a growing public health challenge. These findings highlight the urgent need for effective cancer control strategies and updated epidemiological data to support policy-making.

Indexed as

EpidemiologyIncidenceMortalityProjectionsProstate cancerThailand

Identifiers

PMID41815362
PMCPMC12974151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.